Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB26FL5G0
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $20,514
Award facts
- Contract value 100% obligated
- $20,513.52 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $20,513.52 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml pens on November 6, 2025, with completion expected by November 7, 2025. This non-competitive delivery order represents a firm fixed-price transaction for pharmaceutical products to be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award is issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion comprehensive pharmaceutical support vehicle extending through December 2026 that enables the company to supply a broad range of medications and medical supplies to military healthcare systems globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Conshohocken, Pennsylvania, continues to serve as a critical vendor for federal medical procurement through its established relationship with the Defense Logistics Agency. The company's federal contract portfolio demonstrates extensive experience in delivering specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains to support military and veteran healthcare needs. This delivery order for Dupixent, a specialty immunologic medication, reflects the company's ongoing role in supplying critical pharmaceutical commodities to the Defense Health Agency and other federal healthcare systems.
Quick answers
Who was awarded contract SPE2DB26FL5G0?
SPE2DB26FL5G0 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 6, 2025.
How much is contract SPE2DB26FL5G0 worth?
The government has obligated $20,514 on SPE2DB26FL5G0.
Is contract SPE2DB26FL5G0 an order under another contract?
Yes. SPE2DB26FL5G0 is a delivery order under SPE2DB20D3103, an indefinite delivery contract.
Was contract SPE2DB26FL5G0 competed?
The extent of competition for SPE2DB26FL5G0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award